Processing

Please wait...

Settings

Settings

Goto Application

1. WO2010009377 - METHODS AND COMPOSITIONS FOR PHARMACOGENETIC ANALYSIS OF ANTI-INFLAMMATORY DRUGS IN THE TREATMENT OF RHEUMATOID ARTHRITIS AND OTHER INFLAMMATORY DISEASES

Publication Number WO/2010/009377
Publication Date 21.01.2010
International Application No. PCT/US2009/050959
International Filing Date 17.07.2009
IPC
C12Q 1/68 2006.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
68involving nucleic acids
CPC
C12Q 1/6883
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms
68involving nucleic acids
6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
6883for diseases caused by alterations of genetic material
C12Q 2600/106
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
2600Oligonucleotides characterized by their use
106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
C12Q 2600/156
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
2600Oligonucleotides characterized by their use
156Polymorphic or mutational markers
C12Q 2600/172
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
2600Oligonucleotides characterized by their use
172Haplotypes
Applicants
  • INTERLEUKIN GENETICS, INC. [US]/[US] (AllExceptUS)
  • KORNMAN, Kenneth, S. [US]/[US] (UsOnly)
  • HUTTNER, Kenneth [US]/[US] (UsOnly)
  • ROGUS, John [US]/[US] (UsOnly)
  • KONDRAGUNTA, Venkateswarlu [IN]/[US] (UsOnly)
  • WU, Xaiodong [CN]/[US] (UsOnly)
Inventors
  • KORNMAN, Kenneth, S.
  • HUTTNER, Kenneth
  • ROGUS, John
  • KONDRAGUNTA, Venkateswarlu
  • WU, Xaiodong
Agents
  • ELRIFI, Ivor, R.
Priority Data
61/081,93718.07.2008US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) METHODS AND COMPOSITIONS FOR PHARMACOGENETIC ANALYSIS OF ANTI-INFLAMMATORY DRUGS IN THE TREATMENT OF RHEUMATOID ARTHRITIS AND OTHER INFLAMMATORY DISEASES
(FR) PROCÉDÉS ET COMPOSITIONS POUR UNE ANALYSE PHARMACOGÉNÉTIQUE DE MÉDICAMENTS ANTI-INFLAMMATOIRES DANS LE TRAITEMENT D'UNE ARTHRITE RHUMATOÏDE ET D'AUTRES MALADIES INFLAMMATOIRES
Abstract
(EN)
The invention provides methods and compositions for the pharmacogenetic analysis of anti-inflammatory compounds, especially for the pharmacogenetic association of responsiveness to rheumatoid arthritis medications that target TNFα.
(FR)
L'invention concerne des procédés et des compositions pour l'analyse pharmacogénétique de composés anti-inflammatoires, en particulier pour l'association pharmacogénétique de sensibilité à des médicaments contre l'arthrite rhumatoïde qui ciblent TNFα.
Also published as
Latest bibliographic data on file with the International Bureau